ENTR
Entera Bio Files Articles of Association
Biotechnology company Entera Bio filed its Articles of Association with the SEC, defining terms relevant to its governance and upcoming initial public offering on NASDAQ.
ENTR news
Latest 2 stories · newest Jul 16, 2026
ENTR
Entrada Therapeutics amends 2021 stock plan to increase share reserve.
Entrada Therapeutics amended its 2021 Stock Option and Incentive Plan to raise the maximum share reserve to 3.9 million shares with 4% annual increases. The amendment was approved by the board on March 26, 2026 and by stockholders on June 10, 2026.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same ENTR feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/ENTR/newsSTART FREE